Achyut Healthcare: Zenith Allotment and Main Board 2026

Stock snapshot as of 13 Jul 2026

Achyut Healthcare Ltd was trading around the ₹7.9 level as of July 13, 2026. The closing price reported at 04:01 PM on the same day was ₹7.91. The latest reported P/E ratio at that timestamp was 797.00. The company’s market capitalisation at 04:01 PM on July 13, 2026 was ₹190.91 crore. These figures put recent corporate actions in focus for investors tracking ownership changes and capital structure.

Preferential allotment: what was disclosed

Achyut Healthcare Limited disclosed that Zenith Life Care Private Limited acquired equity shares through a preferential allotment. The regulatory filing referenced is dated March 24, 2026. The allotment itself took place on March 23, 2026, as per the disclosure. Preferential allotments are typically used to raise capital or bring in a strategic shareholder, and they directly change the paid-up equity base.

Zenith Life Care’s acquisition details

Zenith Life Care Private Limited acquired 2,00,000 equity shares in Achyut Healthcare Limited. The disclosure states this represented a 0.08% stake in the company’s total and diluted voting capital. The company also noted that Zenith Life Care is now a registered shareholder in Achyut Healthcare Limited. The update is framed as a completed transaction rather than a proposed one.

How the allotment changed Achyut Healthcare’s equity capital

Following the preferential allotment, Achyut Healthcare’s total equity share capital increased. The disclosed increase was from ₹23,55,57,000 to ₹24,13,57,000. The filing also describes this as a rise in total and diluted voting capital from approximately ₹23.56 crore to ₹24.14 crore. The company added that its total paid-up equity share capital has been enhanced, aligning with the revised post-allotment base.

Migration from BSE SME to BSE Main Board

Achyut Healthcare Limited obtained BSE approval to migrate its equity shares from the SME platform to the Main Board Platform. Trading on the Main Board was set to begin on January 02, 2026. The migration decision was positioned as part of increasing business activities and brand building. According to the company’s disclosures, the Board of Directors decided on this migration in a meeting held on April 17, 2025, and it was approved by shareholders via a postal ballot notice dated April 23, 2025.

Bonus shares: board recommendation and listing reference

The company also disclosed a bonus issue considered and recommended during the year under review. The Board considered and recommended the issue of 6,73,02,000 equity shares of ₹1 each as bonus shares in the ratio of 4:10, meaning 4 new equity shares for every 10 existing equity shares. The disclosure references the board date as December 11, 2024. It also states that the shares are listed with BSE Limited, effective from Wednesday, November 11, 2024. This bonus-share reference sits alongside the migration and preferential allotment as part of the company’s recent capital-market activity.

Company profile and registered address

Incorporated in 1996, Achyut Healthcare Ltd is described as a pharmaceutical trading company. Its stated areas include API, pharmaceutical products, and medical devices. The registered address provided is 610, Colonade, B/H Iscon Temple, Opposite Iscon, BRTS Bus Stand, Iscon - Ambali Road, Ahmedabad, Gujarat, 380058. The contact details include Tel: 079-48982691 and the website http://www.achyuthealthcare.com. The email listed is mahendrazenith@hotmail.com, and the group is marked as not applicable.

Key facts table

Market impact: what changes and what stays the same

The preferential allotment increased Achyut Healthcare’s paid-up equity base, which is a structural change visible in the shift from about ₹23.56 crore to about ₹24.14 crore in total and diluted voting capital. It also introduced Zenith Life Care Private Limited as a registered shareholder, with the disclosed holding at 0.08%. Separately, the migration to the BSE Main Board moved the company from the SME platform into the Main Board framework, with trading set to begin on January 02, 2026. On the market data front, the latest reported snapshot for July 13, 2026 placed the stock at ₹7.91, market cap at ₹190.91 crore, and P/E at 797.00, providing a contemporaneous reference point alongside these corporate updates.

Why investors tracked these updates

For shareholders, the combination of Main Board migration and changes in share capital can alter how the stock is followed in the market. The Main Board migration was linked by the company to increasing business activities and brand building, and it was supported by board and shareholder approvals in 2025 before the trading start date in early 2026. The preferential allotment, meanwhile, is a discrete transaction with clear numbers: 2,00,000 shares, 0.08% stake, and a rise in equity capital to about ₹24.14 crore. Together, these disclosures provide clarity on the company’s listing status and post-allotment capital structure.

Conclusion

Achyut Healthcare’s recent disclosures highlight two key milestones: migration from BSE SME to the BSE Main Board with trading from January 02, 2026, and a preferential allotment to Zenith Life Care that raised equity capital to about ₹24.14 crore. As of July 13, 2026, the stock was reported at ₹7.91 with a market cap of ₹190.91 crore. The next points for investors to monitor are subsequent exchange filings that reflect the updated shareholding and any further capital-market actions referenced by the company.